These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 29084567)

  • 41. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R; Borggreve SE; Dullaart RP
    Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms of disease: proatherogenic HDL--an evolving field.
    Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Ansell BJ; Fogelman AM
    Nat Clin Pract Endocrinol Metab; 2006 Sep; 2(9):504-11. PubMed ID: 16957764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic lipase (LIPC) C-514T gene polymorphism is associated with cardiometabolic parameters and cardiovascular risk factors but not with fatty liver in Mexican population.
    Posadas-Sánchez R; Ocampo-Arcos WA; López-Uribe ÁR; Posadas-Romero C; Villarreal-Molina T; León EÁ; Pérez-Hernández N; Rodríguez-Pérez JM; Cardoso-Saldaña G; Medina-Urrutia A; Vargas-Alarcón G
    Exp Mol Pathol; 2015 Feb; 98(1):93-8. PubMed ID: 25550127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low protective PON1 lactonase activity in an Arab population with high rates of coronary heart disease and diabetes.
    Gugliucci A; Caccavello R; Nassar H; Abu Ahmad W; Sinnreich R; Kark JD
    Clin Chim Acta; 2015 May; 445():41-7. PubMed ID: 25801214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HDL functionality in type 1 diabetes.
    Ganjali S; Dallinga-Thie GM; Simental-Mendía LE; Banach M; Pirro M; Sahebkar A
    Atherosclerosis; 2017 Dec; 267():99-109. PubMed ID: 29102899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.
    Singh S; Venketesh S; Verma JS; Verma M; Lellamma CO; Goel RC
    Indian J Med Res; 2007 Jun; 125(6):783-7. PubMed ID: 17704557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extended-release niacin/laropiprant effects on lipoprotein subfractions in patients with type 2 diabetes mellitus.
    Bays H; Giezek H; McKenney JM; O'Neill EA; Tershakovec AM
    Metab Syndr Relat Disord; 2012 Aug; 10(4):260-6. PubMed ID: 22400810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diabetes and lipid metabolism.
    Athyros VG; Doumas M; Imprialos KP; Stavropoulos K; Georgianou E; Katsimardou A; Karagiannis A
    Hormones (Athens); 2018 Mar; 17(1):61-67. PubMed ID: 29858856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advanced glycated albumin isolated from poorly controlled type 1 diabetes mellitus patients alters macrophage gene expression impairing ABCA-1-mediated reverse cholesterol transport.
    Machado-Lima A; Iborra RT; Pinto RS; Sartori CH; Oliveira ER; Nakandakare ER; Stefano JT; Giannella-Neto D; Corrêa-Giannella ML; Passarelli M
    Diabetes Metab Res Rev; 2013 Jan; 29(1):66-76. PubMed ID: 23015358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paraoxonase-1 activity is positively related to phospholipid transfer protein activity in type 2 diabetes mellitus: Role of large HDL particles.
    Dullaart RPF; Gruppen EG; Dallinga-Thie GM
    Clin Biochem; 2016 Apr; 49(6):508-510. PubMed ID: 26656640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute infection with Epstein-Barr virus is associated with atherogenic lipid changes.
    Apostolou F; Gazi IF; Lagos K; Tellis CC; Tselepis AD; Liberopoulos EN; Elisaf M
    Atherosclerosis; 2010 Oct; 212(2):607-13. PubMed ID: 20594556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Paraoxonase-1 (PON1) activity in patients with coronary artery diseases and in diabetic patients.
    Amine K; Atouk A; Moussamih S; Saile R; Mikou A; Kettani A
    Ann Biol Clin (Paris); 2011; 69(6):671-7. PubMed ID: 22123566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
    Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
    Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between selected oxidative stress markers and lipid risk factors for cardiovascular disease in middle-aged adults and its possible clinical relevance.
    Viktorinova A; Svitekova K; Stecova A; Krizko M
    Clin Biochem; 2016 Aug; 49(12):868-72. PubMed ID: 27240017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipoprotein-associated phospholipase A
    Öngen B; Kalkan Uçar S; Levent E; Azarsız E; Koloğlu T; Çoker M; Sözmen E; Sağın FG
    Ann Clin Biochem; 2017 Sep; 54(5):539-547. PubMed ID: 27614353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 Diabetes.
    Vaisar T; Kanter JE; Wimberger J; Irwin AD; Gauthier J; Wolfson E; Bahnam V; Wu IH; Shah H; Keenan HA; Greenbaum CJ; King GL; Heinecke JW; Bornfeldt KE
    Diabetes Care; 2020 Jan; 43(1):178-186. PubMed ID: 31597668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A study on serum advanced glycation end products and its association with oxidative stress and paraoxonase activity in type 2 diabetic patients with vascular complications.
    Bansal S; Chawla D; Siddarth M; Banerjee BD; Madhu SV; Tripathi AK
    Clin Biochem; 2013 Jan; 46(1-2):109-14. PubMed ID: 23103709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.